Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity

Theodore E. Schall; Kaitlyn Jaffe; Jacob D. Moses

doi:10.1001/amajethics.2024.684

Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity

Theodore E. Schall, Kaitlyn Jaffe, Jacob D. Moses

Bioethics

Research output: Contribution to journal › Article › peer-review

Abstract

This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.

Original language	English (US)
Pages (from-to)	E684-E689
Journal	AMA journal of ethics
Volume	26
Issue number	9
DOIs	https://doi.org/10.1001/amajethics.2024.684
State	Published - Sep 1 2024

ASJC Scopus subject areas

Issues, ethics and legal aspects
Health(social science)
Health Policy

Access to Document

10.1001/amajethics.2024.684

Cite this

@article{7e10ec80de604827bd35ef9c335ed64e,

title = "Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity",

abstract = "This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.",

author = "Schall, {Theodore E.} and Kaitlyn Jaffe and Moses, {Jacob D.}",

year = "2024",

month = sep,

day = "1",

doi = "10.1001/amajethics.2024.684",

language = "English (US)",

volume = "26",

pages = "E684--E689",

journal = "AMA journal of ethics",

issn = "2376-6980",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity

AU - Schall, Theodore E.

AU - Jaffe, Kaitlyn

AU - Moses, Jacob D.

PY - 2024/9/1

Y1 - 2024/9/1

N2 - This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.

AB - This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.

UR - http://www.scopus.com/inward/record.url?scp=85203741674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85203741674&partnerID=8YFLogxK

U2 - 10.1001/amajethics.2024.684

DO - 10.1001/amajethics.2024.684

M3 - Article

C2 - 39250939

AN - SCOPUS:85203741674

SN - 2376-6980

VL - 26

SP - E684-E689

JO - AMA journal of ethics

JF - AMA journal of ethics

IS - 9

ER -

Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this